Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Lifebit Biotech

PR94220

 

LONDON, Jan. 25, 2022 /PRNewswire=KYODO JBN/ --

 

Lifebit today announces a long-term partnership where Lifebit's technology,

Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to

serve as the scalable and secure data management and analysis platform for

researchers at the National Institute for Health Research (NIHR) Cambridge

Biomedical Research Centre (BRC).

 

Photo - https://mma.prnewswire.com/media/1732901/Lifebit.jpg

 

As one of the leading UK biomedical research organisations, the NIHR Cambridge

BRC maintains a secure source of fully consented clinico-genomic data from

patients with chronic diseases and cancer. This biomedical data holds huge

potential for health researchers to unlock discoveries on disease, supporting

recent breakthroughs such as the development of clinical algorithms to guide

precision cancer treatments (https://www.nature.com/articles/s43018-021-00200-0

).

 

With the launch of CYNAPSE, the NIHR Cambridge BRC joins a growing number of

research organisations who are standing up TREs that make use of Lifebit's

pioneering federated technology, designed to take researcher's computation and

analysis to where the data resides, to make sensitive biomedical data securely

accessible. Other examples include Genomics England (

https://lifebit.ai/blog/genomics-england-launches-next-generation-research-platform-central-to-uk-covid-19-response/

) and the Hong Kong Genome Institute (

https://lifebit.ai/blog/lifebit-awarded-a-four-year-contract-for-hong-kongs-genome-project/

).

 

This news comes in the wake of an announcement of the DARE UK consortium effort

between Genomics England, NIHR Cambridge BRC, Eastern AHSN, Cambridge

University Health Partners and Lifebit that will see Lifebit's unique federated

technology bridge the TREs of these leading organisations.

 

"Lifebit is proud to be delivering this next generation federated research

platform, which will allow NIHR Cambridge BRC researchers to more effectively

collaborate at scale and drive a new wave of connected data here in the UK and

globally, accelerating research impact and advancements in patient care." said

Thorben Seeger, Lifebit CBDO.

 

For the full release, click here

(https://lifebit.ai/blog/nihr-cambridge-brc-partners-with-lifebit ).

 

About Lifebit Biotech, Ltd.

 

Lifebit builds enterprise data platforms for use by organisations with complex

and sensitive biomedical datasets. Lifebit's patented federated technology

securely unlocks access to biomedical data. From providing Trusted Research

Environments for national precision medicine programmes to enabling

pharmaceutical companies to discover new drug targets faster, Lifebit empowers

customers to transform how they leverage sensitive biomedical data.

 

About NIHR

The mission of the National Institute for Health Research (NIHR) is to improve

the health and wealth of the nation through research. We do this by:

 

    -- Funding high quality, timely research that benefits the NHS, public

       health and social care;

    -- Investing in world-class expertise, facilities and a skilled delivery

       workforce to translate discoveries into improved treatments and

       services;

    -- Partnering with patients, service users, carers and communities,

       improving the relevance, quality and impact of our research;

    -- Attracting, training and supporting the best researchers to tackle

       complex health and social care challenges;

    -- Collaborating with other public funders, charities and industry to help

       shape a cohesive and globally competitive research system;

    -- Funding applied global health research and training to meet the needs of

       the poorest people in low and middle income countries.

 

NIHR is funded by the Department of Health and Social Care. Its work in low and

middle income countries is principally funded through UK Aid from the UK

government.

 

About NIHR Cambridge Biomedical Research Centre

Based within the most outstanding NHS and University partnerships in the

country, the Biomedical Research Centres are leaders in scientific translation.

Located on the Cambridge Biomedical Campus, they receive substantial levels of

funding from the National Institute for Health Research (NIHR) to translate

fundamental biomedical research into clinical research that benefits patients

and they are early adopters of new treatments.

 

SOURCE  Lifebit Biotech

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中